Donanemab: A New Ray of Hope in the Fight Against Alzheimer's
Listen now
Description
Welcome to the latest episode of our podcast, where we discuss the latest breakthrough in the fight against Alzheimer's disease. In today's episode, we discussed the new monoclonal antibidy, Donanemab, that is offering hope to Alzheimer's patients and their families, and how Donanemab is different from other treatments. Donanemab is a monoclonal antibody that has shown promising results in clinical trials. It works by targeting a protein called amyloid-beta, which is believed to play a significant role in the development of Alzheimer's disease. The drug binds to the amyloid-beta protein and clears it from the brain, reducing the amount of plaque buildup that causes damage to brain cells. While the results of the clinical trials are promising, there are still many challenges to overcome. Donanemab is expensive and requires regular infusions, which may limit its accessibility. There is also a need for further research to determine the long-term effects of the drug and its efficacy in treating different stages of Alzheimer's. Follow us: Join the NEURO Academy: NEUROacademy.com Follow us on social media: Instagram: The Brain Docs @thebraindocs Facebook: The Brain Docs TikTok: @thebraindocs Website: TheBrainDocs.com  
More Episodes
Our brand new show, Your Brain On, is now live! Your Brain On is a podcast about the neuroscience of everything. Each episode will look at an aspect of life through a neuroscientific lens, with science-based stories, interviews, anecdotes, advice, and immersive sounds. We’ll be exploring how...
Published 02/14/24
What happens to your brain when you stop drinking? Is doing Dry January the best way to quit? In this second preview episode of Your Brain On, we discuss the neuroscience and psychology of: • How alcohol affects your brain, at a cellular level • Why a gradual detoxification might be better...
Published 02/07/24